GLOBUS MEDICAL INC
About GLOBUS MEDICAL INC
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $2.9B
- Net income
- $537.9M
- Total assets
- $5.3B
- Market cap
- $10.9B
- Gross margin
- 58.9%
- Operating margin
- 6.6%
- Net margin
- 4.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.5B
- Cost of revenue
- $1.0B
- Gross profit
- $1.5B
- Operating expenses
- $1.3B
- Operating income
- $166.0M
- Income tax
- $17.7M
- Net income
- $103.0M
- EPS (basic)
- $0.76
- EPS (diluted)
- $0.75
Balance sheet
- Total assets
- $5.3B
- Current assets
- $2.2B
- Total liabilities
- $1.1B
- Current liabilities
- $855.9M
- Shareholders’ equity
- $4.2B
Cash flow
- Operating cash flow
- $520.6M
- Investing cash flow
- -$176.1M
- Financing cash flow
- -$27.7M
- Net cash flow
- $317.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $10.9B
- P/E ratio
- 104.4
- EPS (diluted)
- $0.75
- Shares outstanding
- 138.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 3, 2012
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $537.9M in FY2025.
- Revenue grew 219% from FY2020 to FY2024.
- Gross margin of 58.9%, net margin 4.1%.
- Trading 19% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 104.4.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review GLOBUS MEDICAL INC.
Write a review
News about GLOBUS MEDICAL INC
News & sentiment via Polygon.io
